Researchers have developed two new compounds that are able to inhibit SARS-CoV-2 main protease. The study reports one of the compounds is a strong drug candidate for further investigative trials in the treatment of coronavirus.
from Neuroscience News https://ift.tt/2Kw8yMT
Comments
Post a Comment